NICE decision to approve radium-223 only for those men who've already had chemotherapy leaves access for men unsuitable for chemo in doubt.
Prostate Cancer UK welcomes today's government announcement of billions in additional funds for NHS England to spend on drugs and diagnosis up to 2020-21.
It's almost a year since our Movember Centres of Excellence opened their doors for business. Here’s a roundup of what's happened so far.
Meet the vital clinical staff we fund, with support from Movember, to help smooth and improve the process of treatment for men with prostate cancer.
NHS England and NICE have published a document outlining how they plan to work together to reform access to cancer drugs in England. What does it mean for men? We’re on the case to find out.
Glaswegian Alan MacVicar will be taking four friends to play cards on the Caribbean island after scooping PokerStars' prize holiday in our September fundraiser.
BLOG: Sophie Lutter explains the full story behind the 'extremely promising' results from a Swedish trial of a new prostate cancer screening programme.
Number of biopsies reduced by 27 per cent without compromising patients' safety find Swedish trials of a potentially game-changing screening programme for prostate cancer.
Researchers find DNA in blood samples can determine when life-prolonging drug abiraterone has stopped working in men with advanced prostate cancer.
First trial of shorter, more convenient radiotherapy treatment for men with prostate cancer could reduce the number of exhausting visits to hospital.